and comprehensive approach. This information is helpful for identifying inconsistencies of care around the globe to guide strategic development and to further document the current status of ESKD care as a means to monitor future progress. The next steps to enhance kidney care delivery are multifactorial. Preventing ESKD through appropriate AKI and CKD detection programs is essential. Furthermore, supporting non-dialysis CKD through enhanced public funding will slow the progression of kidney disease, thereby reducing the use of expensive and resourceintensive kidney replacement therapies and the burden of ESKD on patients and their families. ISN Global Kidney Health Atlas | 2019 Acknowledgements | 5 ACKNOWLEDGEMENTS Support and financial disclosure declaration This work was funded by the International Society of Nephrology (ISN). The GKHA Co-chairs would like to extend our profound gratitude to all the people that contributed to making this project another great success. We relied on our key stakeholders (leaders of the national nephrology societies and ISN regional board members) to provide and vet information from individual countries and regions. Several individuals have contributed in different ways to make this exercise fruitful despite the complexity of work and tight timeline. In particular, we would like to thank Meaghan Lunney who operationally led the project, drafted the report, and contributed to the analysis plan. We also thank Mohamed Osman for his great contribution and leadership with the desk research. We thank Kara Stephenson Gehman (Academe Partners Limited; academepartners.com) for her help in clarifying the report, and John Labots (John Labots Graphic Design Inc.; johnlabots.com) for presenting our analyses so appealingly. We thank Sandrine Damster, Senior Research Project Manager at the International Society of Nephrology (ISN), for her support in organizing and conducting the survey and her project management expertise. We thank the Alberta Kidney Disease Network (Sue Szigety, Sophanny Tiv) and ISN staff (Luca Segantini, Jo-Ann Donner, Luisa Strani, and Claire Van Der Linden) for their support. The leadership and support of the executive committee of the ISN towards the success of this initiative is greatly appreciated. 6 | Acknowledgements ISN Global Kidney Health Atlas | 2019 Gloria Ashuntantang (Cameroon) Presidential Appointee John Feehally (United Kingdom) ISN Programs Chair David Harris (Australia) President Vivekanand Jha (India) President-Elect Adeera Levin (Canada) Past President Valerie Luyckx (Switzerland) Presidential Appointee Masaomi Nangaku (Japan) Representative of the Council Roberto Pecoits-Filho (Brazil) Representative of the Council Stuart Shankland (USA) Treasurer Charu Malik (Belgium) ISN Executive Director, ex officio ISN Executive Committee (2017-2019) Africa Regional Board Mohammed Benghanem Gharbi (Morocco) Gloria Ashuntantang (Cameroon) Eastern and Central Europe Regional Board Rümeyza Kazancioglu (Turkey) Vladimir Tesar (Czech Republic) Latin America and the Caribbean Regional Board Ezequiel Bellorin-Font (Venezuela) Laura Solá (Uruguay) Middle East Regional Board Mohammed Ghnaimat (Jordan) Shahrzad Ossareh (Iran) NIS and Russia Regional Board Irma Tchokhonelidze (Georgia) Alexander Zemchenkov (Russia) North America and the Caribbean Regional Board Jeffrey Perl (Canada) Kamyar Kalantar-Zadeh (USA) North and East Asia Regional Board Ming-Hui Zhao (China) Chih-Wei Yang (Taiwan) OSEA Regional Board Peter Kerr (Australia) Kriang Tungsanga (Thailand) South Asia Regional Board Vivekanand Jha (India) Harun Ur Rashid (Bangladesh) Western Europe Regional Board Eric Rondeau (France) Paul Harden (United Kingdom) ISN Regional Board Chairs Project Team ISN Global Kidney Health Atlas | 2019 Acknowledgements | 7 Dr. Adeera Levin Founder and Lead, Global Kidney Health Atlas, ISN ISN regional leadership team representatives One board chair or designate from each of the 10 regional teams Dr. Marcello Tonelli Chair, Research Portfolio, ISN Dr. Vivekanand Jha The George Institute for Global Health India, Postgraduate Institute for Medical Education and Research, Chandigarh, India Dr. Kitty Jager Managing Director, ERA-EDTA Registry, Amsterdam, The Netherlands Dr. Fergus Caskey Medical Director, UK Renal Registry Dr. Vlado Perkovic Chair, Advancing Clinical Trials (ISN-ACT), ISN Dr. John Feehally Chair, Programs, ISN Prof. David Johnson, PSM – Co-Chair Department of Nephrology, University of Queensland, Brisbane, Australia Dr. Aminu Bello, PhD – Co-Chair Department of Medicine, University of Alberta, Edmonton, Canada Meaghan Lunney, MSc – Project Manager Department of Community Health Sciences, University of Calgary, Calgary, Canada Phoebe Ye, MSci – Data Analyst Kidney Health Research Group, Department of Medicine, University of Alberta, Edmonton, Canada Dr. Adeera Levin, FRCPC Division of Nephrology, University of British Columbia, Vancouver, Canada Dr. Marcello Tonelli, SM, FRCPC Department of Medicine, University of Calgary, Calgary, Canada Dr. Ikechi G. Okpechi, PhD Division of Nephrology and Hypertension, University of Cape Town, South Africa Prof. John Feehally, FRCP John Walls Renal Unit, Leicester General Hospital,